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Background. The polyomavirus genome contains a noncod-
ing control region (NCCR), which is believed to contain the
enhancer elements that are important activators of viral tran-
scription. We hypothesized that DNA sequence variations in
this region play a role in the pathogenesis of BK virus allograft
nephropathy (BKVAN).
Methods. Tissue sections were prepared from 26 paraffin-
embedded biopsies with BKVAN obtained from 15 patients.
The sections were lysed in a proteinase K buffer and subjected
to DNA sequencing using Big Dye cycle sequencing reactions
run on an automated DNA sequencer (ABI 310). NCCR anat-
omy was compared to the genomic sequence of archetype BKV
strain WW.
Results. Twelve putative transcription factor binding sites
showed nucleotide substitutions, deletions, or duplications in at
least one of the biopsies studied. Changes were most commonly
found in binding sites for granulocyte/macrophage stimulating
factor promoter (24/26 biopsies) and nuclear factor-I (NF-I)
transcription factor (21/22 biopsies). Less frequent changes
were seen at other binding sites, including T antigen (3/22 biop-
sies) and the cytomegalovirus immediate early (CMV IE-1)
promoter (3/22 biopsies). Five biopsies showed complex re-
arrangements reminiscent of those described in JC virus–
associated progressive multifocal leukoencephalopathy.
Conclusion. The regulatory region of BKV shows sequence
heterogeneity in biopsy tissue with viral nephropathy. Se-
quence variations frequently affect putative transcription fac-
tor binding sites, with potential implications for promoter activ-
ity related to genes important in viral replication. Architectural
rearrangements were found in some cases but did not appear
to be a prerequisite for the pathogenesis of BKVAN.
Polyomaviruses are 45 nm-sized particles with a 5 kb
genome [1, 2]. The viral genome is composed of double-
stranded circular, supercoiled DNA arranged in three
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general regions: the noncoding control region (NCCR);
the early coding region, which codes for the small and
large T antigens; and the late coding region, which codes
for the viral capsid proteins VP-1, VP-2, VP-3, and agno-
protein. The direction of early and late transcription is
divergent, with opposite DNA strands participating in
these processes [3]. The NCCR contains the origin of
replication, which marks the point of commencement of
a bidirectional process of DNA replication during the
viral life cycle. It also contains sequence blocks arbitrar-
ily referred to by the alphabetical designations P, Q, R,
and S. These sequence blocks serve as regulatory regions,
or enhancer elements, and are believed to contain several
transcription factor binding sites which putatively modu-
late viral transcription [4]. Naturally occurring simian
virus 40 (SV40), BK polyomavirus (BKV), and JC poly-
omavirus (JCV) strains in the kidney and urine usually
have an archetypal regulatory region, although this is
not an invariable rule [5, 6]. By contrast, JCV found in
the brain tissue of patients with progressive multifocal
leukoencephalopathy (PML) usually shows a variety of
genetic rearrangements [7–9]. There is in vitro evidence
that NCCR variants determine host cell permissiveness
and rate of viral replication [9, 10]. Hence, genetic re-
arrangements are believed to be critical in permitting
viral transcription in the brain, which ultimately culmi-
nates in the pathologic lesions of PML. It is not presently
known if similar genetic alterations are essential for the
pathogenesis of BK virus allograft nephropathy (BK-
VAN) after kidney transplantation, but viruses with re-
arranged NCCRs have been described in nephropathy
associated with other immunosuppressed states [11, 12].
This study investigated the occurrence of viral genetic
rearrangements in kidney biopsy tissue from patients
with BKVAN, and also looked for sequence alterations
in putative transcription factor binding sites within the
NCCR region.
METHODS
Polymerase chain reaction (PCR) was performed on
proteinase K lysates of tissue sections prepared from 26
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formalin-fixed paraffin-embedded renal allograft biop-
sies obtained from 16 patients. Four different primers
were used to amplify the regulatory region of BKV as
previously described [11]. The DNA segments amplified
corresponded to nucleotides 5025-5057 (BRR-1 primer),
371-348 (BRR-2 primer), 50-71 (BRR-5 primer), and
432-411 (BRR-6 primer).
PCR amplification was performed using AmpliTaq
Gold DNA polymerase (Applied Biosystems, Foster
City, CA, USA), beginning with a hot-start incubation
at 95C for 15 minutes. Reactions were run for 40 cycles,
which consisted of a 30 second denaturation at 95C,
followed by annealing at 55C for 30 seconds, and exten-
sion at 72C for 1 minute. After a final extension of 10
minutes at 72C, the reaction was terminated at 4C.
PCR products were resolved on a 3% agarose gel and
visualized by ethidium bromide staining. The gel bands
were cut and purified using glass milk suspension (Gene
Clean II Kit; Q-Bio Gene, Carlsbad, CA, USA).
A cycle-sequencing PCR reaction was set up using the
Big Dye Version 2.0 Terminator cycle sequencing kit
(Applied Biosystems). Primers were added to a final
concentration of 0.5 pmol/L in a final reaction volume
of 20 L. The cycling conditions were 25 cycles of 30
seconds at 96C, 15 seconds at 50C, and 4 minutes at
60C. Reaction was terminated at 4C. Cycle sequencing
products were purified by Centri-Sep columns (Prince-
ton Separations, Adelphia, NJ, USA). DNA sequencing
was performed using an automated sequencer (ABI
Model 310, Applied Biosystems).
Sequences were analyzed by Factura Feature Identifi-
cation Software (Perkin Elmer, Applied Biosystems) the
GCG Wisconsin Package (Accelrys, Madison, WI, USA)
and by Basic Local Alignment Search Tool (BLAST)
programs using a web site maintained by The National
Center for Biotechnology Information (http://www.ncbi.
nlm.NIH.gov). NCCR anatomy was compared with the
BKV WW strain, which is considered to have the arche-
typal regulatory region. The BKV WW sequence was
arbitrarily divided into P, Q, R, and S segments to facili-
tate comparisons between samples [4]. All putative nu-
cleotide changes were confirmed by a second sequencing
reaction using the reverse primer, or by analyzing addi-
tional biopsies with BKVAN.
RESULTS
The archetype NCCR sequence derived from the BKV
WW strain is shown in Figure 1 (first panel from the
top). Deviations of DNA sequences from the archetype
are summarized in Table 1. All assays were performed on
DNA extracted from paraffin-fixed tissue and, as such,
sequence information pertaining to specific DNA seg-
ments could not be obtained from every biopsy (Table
1). Analysis focused on nucleotide sequences with ho-
Fig. 1. Genomic configuration of the noncoding control region in
BKVAN. Panel 1 illustrates the normal anatomy of the noncoding
control region, using the BKV WW strain as the prototype. This portion
of the viral genome is arbitrarily divided into a P segment containing
68 nucleotides, a Q segment containing 39 nucleotides, an R segment
containing 63 nucleotides, and an S segment, also containing 63 nucleo-
tides. The S segment of the noncoding control region is followed by
the agnogene. The actual sequence, written out as the inverse comple-
ment of sequence #M34048 at the National Center of Biotechnology
Information web site is: cacagggaggagctgctaacccatggaatgtagccaaaccat
gacctcaggaaggaaagtgcatgactgggcagccagccagtggcagttaatagtgaaaccccgccc
ctaaaattctcaaataaacacaagaggaagtggaaactggccaaaggagtggaaagcagccagac
agacatgttttgcgggcctaggaatcttggccttgtccccagttaaactggacaa aggcc. Panel 2
illustrates a sequence in which the R segment is truncated to 5 nucleo-
tides, and followed by a partial duplication of the P segment (nucleotides
51-68). Nucleotides 1-36 of the Q segment are followed by an unidenti-
fied sequence that does not match the viral genome. Panel 3 illustrates
a rearranged noncoding control region containing a partial duplication
of the genome encompassing nucleotides Q1 thru Q28 and P14 thru
P68. This duplicated set of nucleotides is inserted at the archetypal P-Q
junction. Panel 4 illustrates a noncoding control region configuration
in which P segment nucleotides 31-48 are deleted. The Q segment is
interrupted at nucleotide 15 by the insertion of a partially duplicated
P segment (nucleotides 49-68). There are no alterations in the R segment
or in the S segment up to nucleotide 48, beyond which no sequence
information could be obtained.
mology to known human transcription factor binding
motifs, as described by Moens et al [4]. The presumption
is that sequence variations at these putative transcription
factor binding regions would have a high probability of
resulting in altered rates of viral DNA replication.
As is seen in Table 1, several putative transcription
binding sites showed nucleotide variations in at least one
of the biopsies studied. Compared to the BKV WW
strain, the most common change was a nucleotide substi-
tution at a position affecting a binding site for granulo-
cyte macrophage colony stimulating factor (GM-CSF)
promoter (24/26 biopsies). Next in frequency were nucle-
otide substitutions at positions affecting binding motifs
for the nuclear factor (NF) family of transcription fac-
tors, including NF-I (21/22 biopsies evaluable for P24-37
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Table 1. Sequence variations at transcription factor binding sites in BK virus regulatory region
Location in BKV BKV WW strain Observed
Transcription factor WW genome sequence sequence # Biopsies
Granulocyte/macrophage stimulating
factor promoter IR10 39-43a tattt ..g.. 22/26 (89.2%)
..c.. 2/26 (7.6%)
deleted 1/26 (3.8%)
NF-I P24-37 tgga atg tag ccaa .... ... c.. .... 21/22 (95.5%)
duplication 3/22 (13.6%)
P31-37 deletion 1/22 (4.5%)
c-mos upstream enhancer P35-41 caaacca duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
Phorbol-inducible element in plasminogen
activator inhibitor type 2 promoter P42-49 tgacctca duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
PEA3 P49-54 aggaag duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
CMV IE-1 promoter P54-59 ggaaag duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
LF-A1 Q1-5 gggca duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
Sp1 Q1-6 gggcag duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
T antigen P68-Q4 tgggc duplication 3/22 (13.6%)
deletion 1/22 (4.5%)
AP-2 Q1-8 ggg cag cc ......g. 2/24 (8.3%)
duplication 4/24 (16.6%)
NF-I P68-Q9 t ggg cag cca ........g. 2/24 (8.3%)
duplication 4/24 (16.6%)
NF-I–like factor binding promoter Q15-19 tggca duplication 4/24 (16.6%)
Periods indicate nucleotides that are not changed with regard to the BKV WW archetype. The location and sequences of the transcription factor binding sites
have been obtained from reference [4].
aThe internal repeat region IR10 is located 120 nucleotides upstream of the P block
segment, 2/24 biopsies evaluable for P68-Q9 segment),
and NF-I–like factor binding promoter (4/24 biopsies).
Five biopsies from three patients with nephropathy
showed complex rearrangements compared to the arche-
type BKV WW strain (Fig. 1). The first patient (second
panel from the top) showed a partially duplicated P block
(sequences P51-68) inserted on the late side of a trun-
cated R segment. This rearrangement could not detected
in two follow-up biopsies from this patient, suggesting
that strains with and without rearrangement were pres-
ent in the allograft kidney. A second patient (third panel)
showed partial duplications of the P and Q segments
inserted at the archetypal P-Q junctions. This altered
regulatory region configuration was confirmed in three
different biopsy samples during follow up of the patient.
The third patient (fourth panel) showed a partial dele-
tion of the P segment (sequences P31-48) and interrup-
tion of the normal Q segment sequence by a duplicated
sequence belonging to the P block (sequences P49-68).
These genetic rearrangements resulted in duplication or
deletion of several transcription factor binding sites, in-
cluding those for GM-CSF, NF-I, c-mos upstream en-
hancer, phorbol-inducible element in plasminogen acti-
vator inhibitor type 2 promoter, PEA3, cytomegalovirus
immediate early (CMV IE-1) promoter, LF-A1, Sp1, T
antigen, and the transcription factor AP-2 binding site.
DISCUSSION
The NCCR region of the BKV genome contains pro-
moters and enhancers with a mosaic of cis-acting ele-
ments involved in the regulation of both early and late
gene transcription [13]. The purpose of this study was
to explore the notion that sequence variations in this
regulatory region might be associated with the pathogen-
esis of BKVAN. We found sequence heterogeneity in
the NCCR region, as previously reported by Sundjford
et al [14] in patients with systemic lupus erythematosus.
These investigators noted that virtually all patients stud-
ied had archetypal BKV, and 8 of 25 viral strains exam-
ined by them showed sequence diversity. A total of 15
point mutations were observed, only 7 of which had been
described in earlier literature. The mutations were shown
to be stable over time in many cases. Similar results were
obtained in another study of BKV isolated from the
urine of bone marrow transplant recipients. This study
found an archetypal genomic configuration with four
“hot spots” of mutation in the regulatory region [15].
It is of interest that the sequence variations we ob-
served affected several putative transcription factor-
binding sites in this region. Transfection assays have
shown that such alterations can alter BKV early pro-
moter activity in Vero cells [4]. Presumably, this is the
result of altered binding affinity of cellular factors to
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appropriate promoter regions that modulate DNA tran-
scription. Potential functional implications of the changes
in binding motifs noted in our study are as follows:
• BKVAN is a disease characterized by variable in-
flammatory infiltrates, which are presumably asso-
ciated with increased activity of the granulocyte
macrophage colony stimulating factor (GM-CSF)
promoter and the corresponding transcription fac-
tors.
• The NF family of transcription factors mediates im-
mune and inflammatory reactions in response to a
variety of stimuli, including those that are likely
to induce BKV gene expression [16, 17]. A point
mutation in the NF-1 binding site has been shown
to have functional consequences with regard to late
viral transcription [16].
• Interactions between CMV and BKV have been
postulated at both the cellular and clinical level
[18–20]. It is, therefore, intriguing that duplications
or deletions in the cytomegalovirus IE-1 promoter
sequence were found in 5 biopsies. One might specu-
late that BKV, CMV, and cellular DNA compete
for the same transcription factors, and sequence
variations in the BKV NCCR region provide the
basis for dynamic interplay between BKV and CMV
replication.
• Mutations in the P68–Q9 part of the regulatory re-
gion result in an increase of approximately 300%
in BKV early promoter activity in Vero cells [4]. It is
interesting to note that this part of the viral genome
contains transcription-binding factors for NF-I and
T antigen.
• PEA3 and Sp1 belong to the Ets family of transcrip-
tion factors, which has demonstrated roles in cellular
differentiation, development, and inhibition of Ras-
mediated transformation [4].
• The transcription factor AP-2 mediates both cyclic-
3,5-adenosine monophosphate (AMP) and phor-
bol-ester–induced transcription. It is known the pro-
tein kinase C and protein kinase A pathways can
induce BKV early gene expression [21, 22].
In addition to transcription binding sites, another im-
portant issue addressed in this study was the overall
architecture of the regulatory region in biopsy tissues
with BKVAN. It is known that BKV excreted in the
urine of individuals without tissue- invasive disease tends
to be in the archetypal NCCR configuration. Thus, most
bone marrow transplant recipients and human immuno-
deficiency virus (HIV) infected patients with asymptom-
atic viruria show no BKV regulatory region rearrange-
ments [14, 15]. Likewise, in an investigation of subjects
with systemic lupus erythematosus, 10/11 patients had
archetypal BKV shed in the urine [14]. In contrast, case
reports of leukemic and HIV-infected patients with viral
nephropathy have stressed the occurrence of rearrange-
ments in the BKV regulatory region [11, 12]. Over-repre-
sentation of restriction fragments representing BKV pro-
moter regions is demonstrated in a patient with renal
cell carcinoma [23]. Such observations have prompted
speculation that a rearranged regulatory region plays an
important role in the pathogenesis of BKV-mediated
tissue injury. The data obtained in the current study from
renal transplant patients, however, show that regulatory
region rearrangements are not required for the develop-
ment of viral nephropathy. Another confounding fact is
the occurrence of BKV regulatory region rearrange-
ments in apparently healthy blood donors [5]. Recently,
it has been shown that the human kidney can serve as
a reservoir for both archetypal and rearranged forms of
the polyomavirus SV40 [24].
In contrast to our data with BKVAN, the late side of
viral origin of DNA replication is almost always re-
arranged in patients with JCV-associated multifocal leu-
koencephalopathy [13]. This suggests that pathogenetic
mechanisms leading to BKVAN differ from those of
JCV-mediated leukoencephalopathy. It may be that the
most important factor in BKV-mediated renal tissue in-
jury is excessive immunosuppression and abrogation of
the normal cellular immune mechanisms that maintain
viral latency. It is significant that the emergence of BKV
nephropathy as a clinical syndrome coincided with the
widespread use of potent immunosuppressive drugs,
such as tacrolimus, cyclosporine microemulsion, siroli-
mus, and mycophenolate mofetil. Alternatively, one could
also argue that in the absence of major gene rearrange-
ments, nucleotide sequence alterations in transcription
binding sites noted earlier might provide the switch from
latent viral infection to lytic disease with tissue destruc-
tion.
CONCLUSION
Even in cases where rearrangements were docu-
mented, our data do not prove that these genetic alter-
ations were actually responsible for tissue invasive disease.
Future work should seek to confirm the effect of BKV
NCCR variations on viral replication in cell culture and
in experimental models of polyomavirus infection.
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